CD8A and neoplasm: As expected, AH1-specific CD8+ T cells were limited to CT26 tumor-bearing mice and were absent both from mice harboring MC38 tumors, which do not present the AH1 peptide, and from tumor-free BALB/c or C57BL/6 mice that were used as the negative control (Figures in S4 Fig).